From Nikkei Asia · · 30s
Takeda's $11bn drug trio targets peak sales
Takeda's new drugs could earn $11bn by 2027.
In brief
Takeda's new drugs could earn $11bn by 2027. Takeda aims to generate up to $11 billion in peak sales from three drugs launching next year. Originally reported by Nikkei Asia.
Takeda's drug trio
Takeda aims to generate up to $11 billion in peak sales from three drugs launching next year.
Stock price rise
Stock price rises to highest level in more than 8 years on expectations.
Drug launches
Takeda releases three major drugs through next year.
At a glance
Takeda aims to generate up to $11 billion in peak sales from three drugs launching next year.
